Kai Ozaki
Hirosaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Annexin A1-Targeted d-Peptide-Monomethyl Auristatin E Conjugate Enhanced Antitumor Effect of Monomethyl Auristatin E for Chemotherapy of Prostate Cancer.
Journal: The Prostate
Published: May 13, 2025
Efficacy of modified enfortumab vedotin ineligible criteria (mEVITA) in advanced urothelial carcinoma.
Journal: Scientific reports
Published: March 10, 2025
Impact of Skin Adverse Events on Prognosis in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin: A Real-World Multicenter Study.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: October 30, 2024
PD-L1 and Ki-67 Expression Before and After Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: October 14, 2024
Relationship between lower urinary tract symptoms and frailty.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: September 22, 2022
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.
Journal: World journal of urology
Published: August 28, 2022
Trends of incidence and age in adults with testicular germ cell tumors: a two-decade multicenter retrospective study.
Journal: Translational andrology and urology
Published: August 10, 2022
Association of oncological response between the first-line chemotherapy and subsequent immune checkpoint inhibitors therapy in patients with unresectable or metastatic urothelial carcinoma.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: December 29, 2021
The influence of gut microbiome on progression of overactive bladder symptoms: a community-based 3-year longitudinal study in Aomori, Japan.
Journal: International urology and nephrology
Published: September 18, 2021
Butyrylcholinesterase level as an independent prognostic factor for overall survival in patients on maintenance hemodialysis: a single-center retrospective study.
Journal: Clinical and experimental nephrology
Published: August 30, 2021
The impact of eligibility for maintenance immunotherapy on prognosis in patients with unresectable or metastatic urothelial carcinoma.
Journal: BJUI compass
Published: May 27, 2021
Showing 1-11 of 11
Last Updated: 09/26/2026